Viking Therapeutics (VKTX) Other Non Operating Income (2016 - 2025)
Historic Other Non Operating Income for Viking Therapeutics (VKTX) over the last 12 years, with Q3 2025 value amounting to $7.8 million.
- Viking Therapeutics' Other Non Operating Income fell 3307.51% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.4 million, marking a year-over-year increase of 755.67%. This contributed to the annual value of $41.0 million for FY2024, which is 17429.68% up from last year.
- Latest data reveals that Viking Therapeutics reported Other Non Operating Income of $7.8 million as of Q3 2025, which was down 3307.51% from $9.0 million recorded in Q2 2025.
- Over the past 5 years, Viking Therapeutics' Other Non Operating Income peaked at $11.8 million during Q2 2024, and registered a low of $142000.0 during Q1 2022.
- In the last 5 years, Viking Therapeutics' Other Non Operating Income had a median value of $4.5 million in 2023 and averaged $4.5 million.
- As far as peak fluctuations go, Viking Therapeutics' Other Non Operating Income plummeted by 8452.61% in 2021, and later skyrocketed by 216884.42% in 2023.
- Quarter analysis of 5 years shows Viking Therapeutics' Other Non Operating Income stood at $154000.0 in 2021, then soared by 370.13% to $724000.0 in 2022, then soared by 546.41% to $4.7 million in 2023, then soared by 131.22% to $10.8 million in 2024, then dropped by 28.16% to $7.8 million in 2025.
- Its Other Non Operating Income was $7.8 million in Q3 2025, compared to $9.0 million in Q2 2025 and $9.8 million in Q1 2025.